A carregar...

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies

Gynecologic malignancies annually account for over 91,000 new cancer cases and approximately 28,000 deaths in the United States. Although there have been advancements in cytotoxic chemotherapies, there has not been significant improvement in overall survival in these patients. While targeted therapi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reinbolt, Raquel E., Hays, John L.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787651/
https://ncbi.nlm.nih.gov/pubmed/24098868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!